GROWTH OF PROTEOLYTIC CLOSTRIDIUM-BOTULINUM IN-PROCESS CHEESE PRODUCTS .2. PREDICTIVE MODELING

被引:17
作者
TERSTEEG, PF
CUPPERS, HGAM
机构
[1] Microbiology and Hygienic Processing, Unilever Research Laboratorium, 3133 AT Vlaardingen
关键词
CLOSTRIDIUM BOTULINUM; PROCESS CHEESE; GROWTH MODELING;
D O I
10.4315/0362-028X-58.10.1100
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Improvement of the accuracy of predictive models for proteolytic Clostridium botulinum stability of current and future process cheese compositions was studied. The results of a central composite design were analyzed the effects of pH (5.45 to 5.9), sodium chloride (1.1 to 2.7%, wt/wt), combinations of citrates and phosphates as emulsifying salts (1.5 to 2%, wt/wt) and temperature (15 to 30 degrees C). Supplemental data enabled assessment of the differences in lactate in moisture (1.0 to 2.6%) originating from the cheese raw materials, variations in moisture (50 to 69%) and the percentage of total fat (0.1 to 41%). The time to a 100-fold increase in cell numbers, t100, was modeled using the SAS-LIFEREG procedure, which can compensate for interval-censored and no-growth values. Two quadratic response models were derived to predict the growth of C. botulinum. The Central Composite Model uses significant (P < 0.01) estimates of the combined effects of pH, total salts (NaCl plus emulsifying salts) in moisture (SIM), citrates as a percentage of total salts (CTS), and temperature. The Extended Total Model uses an additional parameter, lactate in moisture (LACM). The role of fat content was insignificant. Moisture content, which is frequently used, appears to be an unreliable predictor of botulinum stability when fat dry basis (FDB) varies. Both models are capable of predicting the observed stability of compositions derived from the literature. They can complement the historic fully quadratic model of Tanaka, they can be used to assess process cheese safety in relation to distribution and/or storage conditions, and they can accelerate product design, minimizing the use of time-consuming product-challenge tests.
引用
收藏
页码:1100 / 1108
页数:9
相关论文
共 17 条
[1]  
ADAIR C, 1989, Food Microbiology (London), V6, P7, DOI 10.1016/S0740-0020(89)80033-4
[2]  
BAIRDPARKER AC, 1987, J APPL BACTERIOL S, P43
[3]  
BAKER DA, 1992, CLOSTRIDIUM BOTULINU, P359
[4]   CLOSTRIDIUM-BOTULINUM TYPE-A GROWTH AND TOXIN PRODUCTION IN MEDIA AND PROCESS CHEESE SPREAD [J].
BRIOZZO, J ;
DELAGARDE, EA ;
CHIRIFE, J ;
PARADA, JL .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1983, 45 (03) :1150-1152
[5]  
BRIOZZO J, 1985, J FOOD TECHNOL, V20, P383
[6]  
ECKNER KF, 1994, J FOOD PROTECT, V59, P295
[7]   EVALUATION OF THE POTENTIAL FOR BOTULINAL TOXIGENESIS IN REDUCED-SODIUM PROCESSED AMERICAN CHEESE FOODS AND SPREADS [J].
KARAHADIAN, C ;
LINDSAY, RC ;
DILLMAN, LL ;
DEIBEL, RH .
JOURNAL OF FOOD PROTECTION, 1985, 48 (01) :63-69
[8]  
Kosikowski F.V., 1977, CHEESE FERMENTED MIL, V2nd
[9]   SHELF-LIFE OF PASTEURIZED PROCESS CHEESE SPREADS MADE FROM CHEDDAR CHEESE MANUFACTURED WITH A NISIN-PRODUCING STARTER CULTURE [J].
ROBERTS, RF ;
ZOTTOLA, EA .
JOURNAL OF DAIRY SCIENCE, 1993, 76 (07) :1829-1836
[10]   Use of galactosylated-streptavidin as a clearing agent with 111In-labeled, biotinylated antibodies to enhance tumor/non-tumor localization ratios [J].
Govindan, SV ;
Griffiths, GL ;
Michel, RB ;
Andrews, PM ;
Goldenberg, DM ;
Mattes, MJ .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (03) :307-316